We are [5-(3-fluorophenyl)-pyridin-2-ylmethyl]-phosphonic acid diethyl ester CAS:380894-77-9 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name: [5-(3-fluorophenyl)-pyridin-2-ylmethyl]-phosphonic acid diethyl ester
[5-(3-Fluoro-phenyl)-pyridin-2-ylmethyl]-phosphonic acid diethyl ester
[[5-(3-Fluorophenyl)-2-pyridinyl]methyl]phosphonic acid diethyl ester
[5-(3-fluorophenyl)-pyridin-2-ylmethyl]-phosphonic acid diethyl ester
Molecular Formula: C16H19FNO3P
Molecular Weight: 323.29900
Physical and Chemical Properties:
Density: 1.2±0.1 g/cm3
Boiling point: 445.2±45.0 °C at 760 mmHg
Melting point: /
Flash point: 223.1±28.7 °C
Appearance: White powder
Unspecified impurities: for each impurity:≤0.20%
25kg cardboard drum or according to customer specified requirements
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Intermediates of Vorapaxar Sulfate CAS:705260-08-8.
Related News: Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.1,3,5-Benzenetricarboxylic acid chloride Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.1-(4-Hydrazinophenyl)methyl-1,2,4-triazole Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.1-bromo-3-phenylbenzene Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.